Clover Biopharmaceuticals, Ltd.

SEHK:2197 Stock Report

Mkt Cap: HK$1.7b

Clover Biopharmaceuticals Financial Health

Financial Health criteria checks 1/6

Clover Biopharmaceuticals has a total shareholder equity of CN¥-668.1M and total debt of CN¥294.1M, which brings its debt-to-equity ratio to -44%. Its total assets and total liabilities are CN¥4.7B and CN¥5.4B respectively.

Key information

-44.0%

Debt to equity ratio

CN¥294.06m

Debt

Interest coverage ration/a
CashCN¥1.62b
Equity-CN¥668.14m
Total liabilitiesCN¥5.36b
Total assetsCN¥4.69b

Recent financial health updates

Recent updates

Companies Like Clover Biopharmaceuticals (HKG:2197) Are In A Position To Invest In Growth

Mar 17
Companies Like Clover Biopharmaceuticals (HKG:2197) Are In A Position To Invest In Growth

Is Clover Biopharmaceuticals (HKG:2197) In A Good Position To Deliver On Growth Plans?

Nov 29
Is Clover Biopharmaceuticals (HKG:2197) In A Good Position To Deliver On Growth Plans?

Will Clover Biopharmaceuticals (HKG:2197) Spend Its Cash Wisely?

Aug 31
Will Clover Biopharmaceuticals (HKG:2197) Spend Its Cash Wisely?

We're Hopeful That Clover Biopharmaceuticals (HKG:2197) Will Use Its Cash Wisely

Apr 28
We're Hopeful That Clover Biopharmaceuticals (HKG:2197) Will Use Its Cash Wisely

Clover Biopharmaceuticals, Ltd. (HKG:2197) Shares Could Be 28% Below Their Intrinsic Value Estimate

Feb 05
Clover Biopharmaceuticals, Ltd. (HKG:2197) Shares Could Be 28% Below Their Intrinsic Value Estimate

Financial Position Analysis

Short Term Liabilities: 2197 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: 2197 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: 2197 has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: 2197's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 2197 has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: Insufficient data to determine if 2197 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies